文献速递前列腺增生与排尿功能障碍男科与性医学

放疗与非放疗患者人工尿道括约肌翻修与置换的结局及危险因素

Outcomes and Risk Factors of Revision and Replacement Artificial Urinary Sphincter Implantation in Radiated and Nonradiated Cases.
PubMed 文献 · J Urol · 2020-01-17

多中心数据库回顾性分析再次人工尿道括约肌手术的生存率与危险因素。放疗患者初次及第二、三次装置取出时间均早于非放疗者。无其他危险因素者第二次术后5年免翻修率达83.1%,合并放疗和尿道成形术史者降至46%。

要点

  • 放疗者初次括约肌中位取出时间26.4个月,非放疗者35.6个月(p=0.043)。
  • 无危险因素者第二次术后5年免翻修率83.1%,合并放疗和尿道成形术史者仅46%。
  • 多次危险因素并存时翻修率显著升高,术前应充分评估。

核心结论

  • 无额外危险因素者第二、三次人工尿道括约肌手术的免翻修率与初次装置相似。
  • 接受盆腔放疗者人工尿道括约肌并发症出现更早。
  • 多种危险因素并存时免翻修率显著下降。

研究设计与样本

  • 多机构数据库回顾性查询再次人工尿道括约肌手术病例。
  • 放疗组150例,非放疗组174例。
  • 采用Cox比例风险生存分析识别患者与手术危险因素。

主要发现

  • 初次装置中位取出时间放疗组26.4个月,非放疗组35.6个月(p=0.043)。
  • 第二次装置中位取出时间放疗组30.1个月,非放疗组38.7个月(p=0.034)。
  • 第三次装置中位取出时间放疗组28.5个月,非放疗组30.6个月(p=0.020)。
  • 第二次手术5年免翻修率:无危险因素83.1%,放疗史72.6%,尿道成形术史63.9%,放疗加尿道成形术史46%。

关键数值与推荐

  • 放疗与非放疗组初次装置中位取出时间分别为26.4个月与35.6个月(p=0.043)。
  • 第二次装置中位取出时间分别为30.1个月与38.7个月(p=0.034)。
  • 第三次装置中位取出时间分别为28.5个月与30.6个月(p=0.020)。
  • 第二次手术5年免翻修率按危险因素分层为83.1%、72.6%、63.9%和46%。

临床怎么用

  • 术前应评估盆腔放疗史和尿道成形术史等危险因素。
  • 对合并多重危险因素者应告知翻修风险显著升高。
  • 无额外危险因素者再次手术可获得与初次装置相近的免翻修率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Risk factors for complications after artificial urinary sphincter surgery include a history of pelvic radiation and prior artificial urinary sphincter complication. The survival of a second artificial urinary sphincter in the setting of prior device complication and radiation is not well described. We report the survival of redo artificial urinary sphincter surgery and identify risk factors for repeat complications. MATERIALS AND METHODS: A multi-institutional database was queried for redo artificial urinary sphincter surgeries. The primary outcome was median survival of a second and third artificial urinary sphincter in radiated and nonradiated cases. A Cox proportional hazards survival analysis was performed to identify additional patient and surgery risk factors. RESULTS: Median time to explantation of the initial artificial urinary sphincter in radiated (150) and nonradiated (174) cases was 26.4 and 35.6 months, respectively (p=0.043). For a second device median time to explantation was 30.1 and 38.7 months (p=0.034) and for a third device it was 28.5 and 30.6 months (p=0.020), respectively. The 5-year revision-free survival for patients undergoing a second artificial urinary sphincter surgery with no risk factors, history of radiation, history of urethroplasty, and history of radiation and urethroplasty were 83.1%, 72.6%, 63.9% and 46%, respectively. CONCLUSIONS: Patients without additional risk factors undergoing second and third artificial urinary sphincter surgeries experience revision-free rates similar to those of their initial artificial urinary sphincter devices. Patients who have been treated with pelvic radiation have earlier artificial urinary sphincter complications. When multiple risk factors exist, revision-free rates decrease significantly.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Fuller TW, Ballon-Landa E, Gallo K, et al. Outcomes and Risk Factors of Revision and Replacement Artificial Urinary Sphincter Implantation in Radiated and Nonradiated Cases. J Urol. 2020. PMID: 31951498. doi:10.1097/JU.0000000000000749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。